myeloma

Israeli commercial stage biopharmaceutical company BioLineRx Ltd. (Nasdaq: BLRX; TASE: BLRX) today announced that the US Food and Drug Administration (FDA) has approved APHEXDA (motixafortide) in combination with…

LOS ANGELES, July 13, 2023 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) today announced that a 2023 IMF Patient and Family Seminar (PFS) will take place in-person from August 18-19 at the Sofitel Los Angeles at Beverly…

SOUTH SAN FRANCISCO, Calif., June 27, 2023 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (Nasdaq: HARP), a clinical-stage immuno-oncology company developing novel T cell engagers, today announced the completion of planned patient…

Elana Gotkine THURSDAY, June 8, 2023 (HealthDay News) -- For patients with lenalidomide-refractory multiple myeloma, a single cilta-cel infusion results in lower risk of disease progression or…

LOS ANGELES, June 01, 2023 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) is proud to announce the recipients of this year’s Robert A. Kyle Achievement Award and Brian G.M. Durie Outstanding Achievement Award. The…

<!-- Name:DistributionId Value:8846127 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value: -->…

<!-- Name:DistributionId Value:8840704 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value: -->…

<!-- Name:DistributionId Value:8839953 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value: -->…

Elana Gotkine MONDAY, April 24, 2023 (HealthDay News) -- For patients with multiple myeloma (MM), there has been an improvement in prognosis since 2000, but mortality still remains elevated, according…

<!-- Name:DistributionId Value:8793588 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:5377 -->…